Medtronic MDT Ratios & Valuation
| Q4 '26 | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 65%-0.3pp | 64.9%-0.4pp | 65.5%+0.5pp | 65.3%+0.1pp | 65.3%0.0pp | |
| Operating margin | 17.8%0.0pp | 17%+0.2pp | 17.9%+1.5pp | 17.9%+2.1pp | 17.8%+1.9pp | |
| Net margin | 13.2%-0.7pp | 13%+0.2pp | 13.7%+0.7pp | 13.6%+1.6pp | 13.9%+2.5pp | |
| EBITDA margin | 25.9%-0.4pp | 25.7%+0.8pp | 26.6%+2.2pp | 26.5%+2.6pp | 26.3%+2.2pp | |
| Free cash flow margin | 14.9%-0.5pp | 15.2%-1.2pp | 15%-1.7pp | 15.5%-0.3pp | 15.5%-0.6pp | |
| Returns | ||||||
| Return on equity | 9.8%+0.4pp | 9.4%+1.0pp | 9.8%+1.2pp | 9.7%+1.8pp | 9.5%+2.3pp | |
| Return on assets | 5.2%+0.1pp | 5.1%+0.4pp | 5.3%+0.5pp | 5.2%+0.8pp | 5.1%+1.1pp | |
| Return on invested capital | 6.7%+0.1pp | 6.7%+0.6pp | 6.9%+0.9pp | 6.8%+1.2pp | 6.6%+1.4pp | |
| Efficiency | ||||||
| Asset turnover | 0.4×0.0× | 0.4×0.0× | 0.4×0.0× | 0.4×0.0× | 0.4×0.0× | |
| Inventory turnover | 2.2×+0.1× | 2.1×+0.1× | 2.1×0.0× | 2.1×+0.1× | 2.2×0.0× | |
| Liquidity | ||||||
| Current ratio | 2.1×+0.3× | 2.5×+0.6× | 2.4×+0.6× | 2×-0.1× | 1.8×-0.2× | |
| Quick ratio | 1.6×+0.2× | 1.9×+0.4× | 1.8×+0.4× | 1.5×-0.1× | 1.4×-0.1× | |
| Cash ratio | 0.2×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | 0.2×+0.1× | |
| Leverage | ||||||
| Debt-to-equity | 0.6×0.0× | 0.6×0.0× | 0.6×0.0× | 0.6×0.0× | 0.6×+0.1× | |
| Debt-to-assets | 0.3×0.0× | 0.3×0.0× | 0.3×0.0× | 0.3×0.0× | 0.3×0.0× | |
| Net debt / EBITDA | 2.9×-0.2× | 3×-0.1× | 3×-0.3× | 3×-0.4× | 3.1×-0.1× | |
| Interest coverage | 9.1×+0.9× | 8.5×+1.1× | 8.8×+1.7× | 8.3×+1.3× | 8.2×+1.0× | |
| Per Share | ||||||
| Book value per share | $38.40+3.1% | $37.99-1.1% | $37.77+0.2% | $37.21+0.6% | $37.23-1.4% | |
| Valuation | ||||||
| Market capitalization | $103.96B-3.8% | $132B+13.3% | $116.33B+0.8% | $115.62B+8.9% | $108.12B+1.3% | |
| Enterprise value | $131.22B-3.2% | $158.98B+12.1% | $144.21B+1.3% | $143.01B+7.7% | $135.58B+3.1% | |
| Price / earnings | 21.7×-1.5× | 28.6×+1.3× | 24.4×-2.5× | 24.8×-2.2× | 23.2×-5.8× | |
| Price / sales | 2.9×-0.4× | 3.7×+0.2× | 3.3×-0.2× | 3.4×+0.1× | 3.2×-0.1× | |
| Price / book | 2.1×-0.1× | 2.7×+0.3× | 2.4×0.0× | 2.4×+0.2× | 2.3×+0.1× | |
| EV / EBITDA | 13.9×-1.5× | 17.4×+0.2× | 15.6×-2.1× | 15.8×-1.3× | 15.4×-1.5× | |
| EV / sales | 3.6×-0.4× | 4.5×+0.2× | 4.1×-0.2× | 4.2×+0.1× | 4×0.0× | |
| Free cash flow yield | 5.2%+0.4pp | 4.1%-0.6pp | 4.5%-0.3pp | 4.6%-0.3pp | 4.8%-0.1pp | |
| Earnings yield | 4.6%+0.3pp | 3.5%-0.2pp | 4.1%+0.4pp | 4%+0.3pp | 4.3%+0.9pp | |
| Dividend yield | 3.5%+0.2pp | 2.7%-0.3pp | 3.1%0.0pp | 3.1%-0.3pp | 3.3%-0.1pp | |
| PEG ratio | 7.3×+6.4× | 3.5×-16.0× | 2.2×-3.7× | 1.3×-1.8× | 0.9×— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Medtronic's profit margins?
- Medtronic (MDT) runs a 64.9% gross margin and a 17.0% operating margin, with a 13.0% net margin.
- Where do Medtronic's ratios come from?
- Every ratio is computed from Medtronic's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
